Nanolive
Nanolive develops automated label-free live cell imaging and analysis platforms, such as the 3D Cell Explorer, which utilize holotomography and AI-powered digital assays. The technology allows for the non-invasive, quantitative assessment of cellular dynamics, including mitochondrial health, cytotoxicity, and T cell interactions, without the use of fluorescent dyes or labels. The company primarily serves the biotechnology and pharmaceutical industries to accelerate drug discovery and research in oncology, metabolism, and cosmetics.
Funding summary
- Total raised
- €23.4M
- Funding rounds
- 4
Investors in Nanolive
Investors on record for Nanolive. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Nanolive?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors